SCO-spondin from embryonic cerebrospinal fluid is required for neurogenesis during early brain development

The central nervous system (CNS) develops from the neural tube, a hollow structure filled with embryonic cerebrospinal fluid (eCSF) and surrounded by neuroepithelial cells. Several lines of evidence suggest that the eCSF contains diffusible factors regulating the survival, proliferation, and differentiation of the neuroepithelium, although these factors are only beginning to be uncovered. One possible candidate as eCSF morphogenetic molecule is SCO-spondin, a large glycoprotein whose secretion by the diencephalic roof plate starts at early developmental stages. In vitro, SCO-spondin promotes neuronal survival and differentiation, but its in vivo function still remains to be elucidated. Here we performed in vivo loss of function experiments for SCO-spondin during early brain development by injecting and electroporating a specific shRNA expression vector into the neural tube of chick embryos. We show that SCO-spondin knock down induces an increase in neuroepithelial cells proliferation concomitantly with a decrease in cellular differentiation toward neuronal lineages, leading to hyperplasia in both the diencephalon and the mesencephalon. In addition, SCO-spondin is required for the correct morphogenesis of the posterior commissure and pineal gland. Because SCO-spondin is secreted by the diencephalon, we sought to corroborate the long-range function of this protein in vitro by performing gain and loss of function experiments on mesencephalic explants. We find that culture medium enriched in SCO-spondin causes an increased neurodifferentiation of explanted mesencephalic region. Conversely, inhibitory antibodies against SCO-spondin cause a reduction in neurodifferentiation and an increase of mitosis when such explants are cultured in eCSF. Our results suggest that SCO-spondin is a crucial eCSF diffusible factor regulating the balance between proliferation and differentiation of the brain neuroepithelial cells.


INTRODUCTION
After the closure of the anterior neuropore, the cranial region of the neural tube enlarges and generates the encephalic vesicles. During early development stages, these vesicles are delineated by the neuroepithelium, a pseudostratified epithelium that will eventually generate all the neurons and glial cells of the anterior adult central nervous system (CNS). The brain vesicles are filled with embryonic cerebrospinal fluid (eCSF), which plays important roles in encephalic development at both embryonic and fetal stages, regulating the survival, proliferation, and neural differentiation of the neuroepithelial progenitor cells Salehi and Mashayekhi, 2006;Gato and Desmond, 2009;Zappaterra and Lehtinen, 2012). It has been proposed that the eCSF exerts its function by controlling neuroepithelial proliferation in response to internal liquid pressure (Desmond et al., 2005) and by facilitating the interaction of diffusible factors with the neuroepithelial cells apical surface (Gato and Desmond, 2009). The existence and importance of such diffusible factors have been demonstrated in vitro on mesencephalic and cortical explants, which develop normally in the presence of eCSF, whereas the absence of eCSF causes a decrease in neuroepithelial cells proliferation, differentiation, and survival Lehtinen et al., 2011). The eCSF of avians (chick) and mammals (rodents and human) displays a dynamic expression pattern of hundred of proteins including essential growth and survival factor for the developing brain (Parada et al., 2005Zappaterra and Lehtinen, 2012). Indeed, the main constituents of eCSF are proteins whose enrichment is 30-fold higher at embryonic stages than in the adult cerebrospinal fluid (Birge et al., 1974;Dziegielewska et al., 1980). Proteomic analysis of eCSF revealed the presence of several factors related to cell differentiation or proliferation such as fibroblast growth factors (Martin et al., 2006), insulin-like growth factors , sonic hedgehog (Huang et al., 2010), Wnts (Lehtinen et al., 2011), lipoproteins (Parada et al., 2008), and nerve growth factor . While most of these proteins have a serous origin (Gato et al., 2004); some of them are directly secreted into the eCSF, such as Shh (Huang et al., 2009) or IGF-1 which are produced by the choroid plexus .
Although the analysis of eCSF has gained recent attention as a promising avenue in the success of neuronal stem cell technology (Zappaterra and Lehtinen, 2012), the factors responsible for its effects are only beginning to be uncovered. One possible candidate as an eCSF morphogenetic molecule is SCO-spondin. This high molecular mass glycoprotein is secreted to the eCSF by the subcommissural organ (SCO), a highly conserved brain gland present throughout the vertebrate phylum (Rodriguez et al., 1992(Rodriguez et al., , 1998Meiniel and Meiniel, 2007). The SCO is one of the first structures to differentiate in the chick brain, expressing SCOspondin as early as the third day of development (Didier et al., 2007;Caprile et al., 2009). This structure is located at the dorsal diencephalic-mesencephalic boundary, which, according to the prosomeric model, corresponds to the roof plate of prosomere 1, underneath the posterior commissure (PC). The SCO is composed of radial glial cells whose apical domains face the third ventricle and, hence, contact the cerebrospinal fluid, whereas their basal domains extend single processes that cross the nerve bundles of the PC and are attached to the pial membrane (Sterba et al., 1982;Rodriguez et al., 1992Rodriguez et al., , 1998. In spite of the fact that the sequence of SCO-spondin was reported more than 10 years ago (Didier et al., 2000), its precise function still remains to be elucidated. With respect to its biochemical structure, SCO-spondin is a giant glycoprotein of more than 5000 amino acids that display a multidomain organization, including the presence of several thrombospondin repeats (TSR), low-density lipoprotein receptor type A repeats (LDLrA), EGFlike domains, von Willebrand factor domains (vWF), one emilin (EMI) motif, and a C-terminal cystine knot (CTCK) (Didier et al., 2007). The presence of some of these domains has been reported in other proteins related with neurogenesis like thrombospondin 1 or reelin (Adams and Tucker, 2000;Panteri et al., 2006;Lu and Kipnis, 2010).
SCO-spondin is secreted apically, to the cerebrospinal fluid, as well as basally, toward the extracellular matrix contacting the axons of the PC (Caprile et al., 2009). The best characterized route of SCO-spondin secretion is toward the cerebrospinal fluid where it aggregates and forms the Reissner's fiber (RF); a threadlike dynamic structure that grows caudally from the SCO through the fourth ventricle and the central canal of the spinal cord, where it is finally degraded at the level of the ampulle caudalis (Molina et al., 2001). The RF has been proposed to regulate CSF production, composition, and circulation (Cifuentes et al., 1994;Rodriguez and Yulis, 2001;Caprile et al., 2003). However, the appearance of RF occurs several days after the onset of SCOspondin secretion, indicating that, at least during this period, this protein remains soluble in the eCSF. The possible SCOspondin neurogenic role during early development is suggested by in vitro experiments, where solubilized RF or peptides derived from the SCO-spondin sequence promote the survival (Monnerie et al., 1997) and differentiation (El Bitar et al., 2001) of neuronal cells.
Considering the early secretion of SCO-spondin, its biochemical structure, and the neurodifferentiation effect observed in vitro, we hypothesized that SCO-spondin affects the behavior of neuroepithelial cells during early brain development. To test this hypothesis, we used a loss of function approach in chick embryos by injecting and electroporating a SCO-spondin-specific shRNA expression vector into the neural tube. Our results show that SCO-spondin is crucial for PC formation and for proper brain development. The absence of this protein generates an increase in neuroepithelial cells division in vivo, showing ectopic cellular cluster in the diencephalon and mesencephalon, at the expense of cellular differentiation toward the neuronal lineage. The longrange mode of action of this protein is further supported by in vitro experiments, in which mesencephalic explants cultured in SCO-spondin depleted eCSF leads to a dramatical reduction of neurodifferentiation and an increase in mitosis of neuroepithelial cells.

CHICK EMBRYOS
Fertilized chick eggs were incubated at 38 • C in a humidified incubator for specific time intervals. Embryos were staged according to Hamburger and Hamilton (1992). Experiments were conducted following the guidelines outlined in the Biosafety and Bioethics Manual of the National Commission of Scientific and Technological Research (CONICYT, Chilean Government) and the Ethics Committee of the University of Concepción.

IMMUNOHISTOCHEMISTRY
Embryos were fixed for 24 h in Carnoy, dehydrated in ascending concentrations of alcohols and embedded in paraplast. Brains were oriented to obtain 5-7 μm thick sagittal sections of prosomere 1. Sections were immunostained with mouse monoclonal primary antibodies raised against vimentin and NCAM cytoplasmic domain (H5 and 4D, respectively, from Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) as well as with a rabbit anti Reissner's fiber glycoproteins antibody (AFRU) that recognizes SCO-spondin (Caprile et al., 2009), a mouse anti-βIII tubulin antibody (clone Tuj1, Promega, Madison, WI, USA) and an anti-proliferating cell nuclear antigen (PCNA, PC10 ab29 Abcam). Antibodies were diluted in Tris-HCl buffer containing 1% bovine serum albumin (TRIS-BSA). Goat anti-mouse Alexa-546 and anti-rabbit Alexa-488 antibodies (Invitrogen, Carlsbad, CA) were diluted 1:100 in TRIS-BSA and incubated for 2 h at room temperature. Nuclei were visualized with TOPRO-3 (Invitrogen, Carlsbad, CA). For peroxidase staining, sections were incubated with a secondary goat anti-rabbit IgG coupled to peroxidase (Jackson Immunoresearch, West Grove, PA) diluted 1:100 in the same buffer. Images were acquired with a laser confocal Nikon Eclipse TE2000-U microscope.

SCANNING ELECTRON MICROSCOPY
Stage HH18 Chick embryos were fixed for 2 h by immersion in 2.5% glutaraldehyde buffered to pH 7.4 with 0.1 M phosphate. After manually performing a sagittal cut through the midline of the brain, the tissue was dehydrated in ethanol until criticalpoint drying, ion covered with gold, and examined with an Etec microscope (Etec Corp., Hayward, CA) (del Brio et al., 2000).

eCSF EXTRACTION
eCSF from stages HH23-HH34 embryos was obtained as previously described (Gato et al., 2004) with small modifications. In order to avoid contamination with neuroepithelial cells, eCSF was gently sucked up under the dissecting microscope with a glass micro-needle, carefully introduced into the middle of the mesencephalic cavity. To minimize protein degradation, eCSF samples were kept at −15 • C with a protease inhibitor cocktail (Sigma P2714), aliquoted, and frozen at −80 • C until used.

WESTERN BLOT
For immunoblot analysis, 25 μg of total proteins were extracted from stage HH23-34 eCSF or from DMEM (Sigma) conditioned with stage HH36 subcommissural organ explants. Samples were fractionated by electrophoresis in 3%-15% linear gradient sodium dodecyl sulfate polyacrylamide gels and subsequently electrotransferred onto nitrocellulose membrane in a buffer containing 25 mM TRIS-HCl, pH 8.3, 192 mM glycine, 0.2% SDS and 20% methanol, at 25 mA, for 14 h (Towbin et al., 1979). Non-specific protein binding sites were blocked by incubating the nitrocellulose membranes with 5% non-fat milk in 0.1 M phosphate buffered saline buffer containing 0.1% Tween-20, for 2 h at room temperature. Membranes were probed with the AFRU antibody (1:15,000) overnight. Anti-IgG rabbit secondary antibodies (1:5000) (Jackson Immunoresearch) were incubated for 2 h at room temperature. Immunoreactive proteins were detected with an enhanced chemiluminescence system (SuperSignal, Pierce, Rockford, IL), as instructed by the manufacturer.

CULTURE AND TRANSFECTION OF SCO-CELLS
Cultured glial SCO cells were obtained from HH34 chick embryos. Briefly, the prosomere 1 roof plate was dissected and digested for 10 min with trypsin 0.12% (wt/vol) in phosphate buffer 0.1 M (pH 7.4, 320 mOsm) and further triturated to homogeneity with a fire-polished Pasteur pipette. 100,000 cells per well were plated onto glass coverslips in a 12-wells plate and incubated for 3 days with Dulbeco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum, penicillin and streptomycin. Transfection of shRNA-SCOspondin was carried using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. The expression of SCO-spondin was analyzed by immunohistochemistry. The transfection of the plasmid was corroborated by the expression of GFP. Images were acquired with a laser confocal Nikon Eclipse TE2000-U microscope.

INJECTION AND ELECTROPORATION OF shRNA-SCO-SPONDIN in ovo
The injection and electroporation in ovo was performed as described in Krull (2004) with some modifications. Briefly, the neural tube of HH 9-11 embryos was injected with 1 mg/ml plasmid DNA containing 0.1% Fast Green (Sigma) for visual monitoring of the injection. Several drops of chick Ringer's solution were dropped onto the embryo after DNA injection. Electrodes were placed above (cathode) and below (anode) the diencephalon. Conditions used for electroporation were five Squarewave electrical pulses of 25 V, 50 ms pulse length, using the Ovodyne electroporator TSS20 (Intracel, Royston Herts, UK) and platinum electrodes. Following manipulation, the eggs were sealed with Parafilm (American National Can™, Greenwich, CT) and returned to the incubator. Twenty-four to thirty-six hours after electroporation, GFP expression was analyzed and embryos displaying expression at the level of the dorsal diencephalon were returned to the incubator until harvesting at HH29.

ORGANOTYPIC CULTURES OF MESENCEPHALIC NEUROECTODERM
Organotypic cultures of HH20 optic tecta were performed as described by Gato et al. (2005) and maintained at 37 • C with 5% CO2 for 24 h in the presence of 0.01 mM 5-Bromo-2deoxyuridine (BrdU, Sigma) and one of the four following media: (1) DMEM (Sigma), (2) SCO-spondin positive conditioned medium obtained from the supernatant of HH36 SCO organ cultures maintained for 4 days in DMEM, (3) 80% DMEM with 20% stage HH25 eCSF, and (4) 80% DMEM with 20% stage HH25 eCSF and supplemented with a 1:300 dilution of the AFRU anti SCO-spondin antibody. After 24 h, the explants were fixed in paraformaldehide 4% and processed for immunohistochemistry to monitor proliferation (anti-BrdU antibody), apoptosis (anti-caspase 3 antibody), and neuronal differentiation (anti-βIII tubulin antibody). The positive areas of explants stained with each antibody as well as the total explant area were analyzed with the Image J program. Error bars represent s.e.m. and statistical analyses were performed using the Student's t-test. Differences were considered significant for p < 0.05.

SCO-SPONDIN IS PRESENT IN THE eCSF FROM EARLY STAGES OF DEVELOPMENT
To precisely describe the spatiotemporal expression pattern of SCO-spondin, we performed immunohistochemical staining on Frontiers in Cellular Neuroscience www.frontiersin.org June 2013 | Volume 7 | Article 80 | 3 chick embryo sections from early developmental stages. SCO spondin was first detected at stage HH17 in the diencephalic roof plate (Figures 1A-D) where it was restricted to the apical domain, suggesting its secretion to the eCSF (arrows in Figure 1D). At this stage, the diencephalic roof plate is similar to the rest of the neuroepithelium, consisting of a pseudostratified epithelium, whose basal and apical domains contact the eCSF and the external limiting membrane, respectively (Figures 1E-F).
The possible secretion of SCO-spondin to the eCSF was confirmed by western blot performed on eCSF from chick embryos at different stages of development (Figure 2). The results show that at HH23 (fourth day of development) the anti SCO-spondin recognizes four bands of 175, 140, 65, and 50 kDa; while at later stages additional bands of 350, 300, and 200 kDa appear, which is in agreement with previous reports (Hoyo-Becerra et al., 2006;Vio et al., 2008). Similar bands are found in the conditioned medium from HH36 SCO explants, with the exception of the smaller bands of 65 and 50 KDa (Figure 2, CM lane).

SCO-SPONDIN BINDS TO THE APICAL DOMAIN OF NEUROEPITHELIAL CELLS in vivo
The presence of SCO-spondin in the eCSF of early chick embryos led us to investigate if this glycoprotein interacts with the apical side of neuroepithelial cells. For this purpose, we realized immunohistochemistry with anti SCO-spondin on sectioned HH23 chick brains embryos (Figure 3). The results show that the immunoreaction is exclusively localized to the cells bodies present in the diencephalic roof plate (Figures 3A,B,D,E). At this stage the immunoreaction covers the entire cell, including the apical region in contact with the eCSF (arrows in Figures 3B,E) as well as the basal region in contact with the NCAM-positive axons of the PC (arrowheads in Figure 3E). The rest of the neuroepithelium is immunonegative for SCO-spondin, except for a thin line covering the apical region of mesencephalic apical membrane (arrows in Figure 3C) and a weak signal observed in the medial and basal part of the mesencephalic cells. In order to confirm the SCO-spondin binding to the neuroepithelial apical membrane, the SCO-spondin antibody was injected to the eCSF of live HH24 embryos. After 24 h, animals were sacrificed and the localization of the SCO-spondin antibody was assessed with anti-rabbit IgG. Our results confirm the binding of anti-SCO-spondin to the apical membrane of neuroepithelial cells in vivo (Figures 4A-C). The negative control, where unrelated antibodies were injected in the same way showed no immunoreaction (Figures 4D-F).

In ovo INHIBITION OF SCO-SPONDIN
In order to analyze the function of SCO-spondin in ovo during early CNS development, we designed a plasmid allowing the co-expression of GFP with a SCO-spondin specific shRNA or with a control scrambled shRNA. The high efficiency of the shRNA was first confirmed on primary culture of chick SCO-cells expressing SCO-spondin, showing that even though the number of transfected cells was low, all of them were immunonegative for SCO-spondin (Figures 5A,B). After the injection of the vector into the neural tube of HH11 embryos (Figure 5C), electroporation of the diencephalic roof plate was performed by placing the positive electrode at the dorsal diencephalic region and the negative electrode beneath the embryo ( Figure 5D). One day after electroporation, the GFP expression was monitored in order to ensure that the expression of the plasmid occurred in the accurate region (Figure 5E), and the selected embryos were left to develop until stage HH29 before being examined. From the total of the electroporated embryos, nine of them displayed GFP expression at the level of the diencephalic roof plate and survived until stage HH29. Immunohistochemical analysis with the anti-SCOspondin antibody revealed that these animals can be separated into two different groups according to their phenotypes: (1) animals inhibited at the level of the cephalic region of the SCO. This group includes animals with complete inhibition and others expressing SCO-spondin exclusively at the level of the caudal region, and (2), animals in which SCO-spondin is specifically and exclusively inhibited at the level of the caudal or the central region of the SCO. Below, we will describe the consequences of these different types of inhibition on the development of the diencephalon (Figure 6) and the mesencephalon (Figure 7). The diencephalon developed normally in animals that received the scrambled shRNA. Such control animals present a SCOspondin positive region of 700 μm in length occupying an area of approximately 9800 μm 2 , located precisely below the PC (Figures 6A-C). Under normal conditions, cells of the SCO extend basal prolongations that emerge from the cell body, traverse the PC, dividing this axonal tract in fascicles, and attach to the external limitant membrane (arrows in Figure 6C). The size of the PC fascicles grows progressively in rostro-caudal direction, being smaller at the rostral region. Hence, the length of the basal prolongations of the SCO cells is variable and closely correlates with the thickness of the PC fascicles. At this stage, the primordium of the pineal gland is present at the level of the dorsal diencephalon, rostraly to the SCO (Figure 6A). The diencephalon of animals in which SCO-spondin is inhibited caudally (n = 3) presents a diminution of 32 ± 9% in the PC area, which nevertheless displays a normal degree of axonal fasciculation, and a pineal gland primordium similar to the control (Figures 6D-F). We obtained one animal showing inhibition at the level of the central region, whose phenotype was similar to animals inhibited caudally with a small fasciculated PC, and presence of a normal pineal gland primordium (Figures 6G-I). In such animal, SCO cells have lost their radial morphology and present nuclei in the entire thickness of the SCO. Remarkably, while central inhibition abrogates SCO-spondin expression in the cell bodies, this protein is still strongly detected on the apical side of the SCO cells (asterisk in Figure 6I). Cephalic inhibition of SCO-spondin (Figures 6J-L) does not affect the PC area but causes a higher grade of axonal defasciculation (arrow in Figure 6L). Such animals (n = 3) lack the pineal gland primordium and show ectopic cellular clusters located in the dorsal diencephalon (asterisks in Figure 6J). Likewise, animals with complete inhibition (n = 2, see Figures 6M-O) lack a pineal gland and exhibit ectopic cellular cluster in the dorsal diencephalon (asterisks in Figure 6M). Additionally, complete inhibition causes a drastic diminution in the number of PC axons which are replaced by βIII tubulin positive cell bodies (inset in Figure 6O).
With respect to the mesencephalic region, the optic tectum of WT and control animals that received the scrambled shRNA display a normal and homogeneous thickness of 75±15μm which positively stains for βIII tubulin in its dorsal-most border (Figures 7A-C). The level of cell proliferation was revealed by the presence of a nuclear immunostaining of PCNA in 31 ± 4.3% of the cells (Figures 7D-E). Histological analysis reveals a discrete presence of mitotic spindles on the cells contacting the cerebrospinal fluid (arrows and inset in Figure 7F). The apical border of these cells consists of an homogeneous, uninterrupted, epithelium, and presents immunoreaction for anti SCO-spondin (inset in Figure 7C). Animals in which SCO-spondin was inhibited in the caudal region of the SCO (Figures 7G-L) present a normal optic tectum with a SCO-spondin immunoreactivity at the level of the apical surface (arrows in Figure 7I) and a level of βIII tubulin ( Figure 7H-I), and PCNA (Figures 7J-K) immunoreaction similar to the control embryos. By contrast, the general mesencephalic morphology was severely affected in embryos with total inhibition, or in embryos displaying an inhibition localized to the cephalic region of the SCO (Figures 7M-X). Such embryos present a thicker neuroepithelial wall, including the presence of numerous undifferentiated cells (asterisk in Figures 7M,S). βIII tubulin immunoreactivity is highly reduced, particularly in animals with total inhibition (Figure 7U) and the PCNA immunoreactivity is dramatically increased and is present in both the cell nucleus and the cytoplasm. This localization of PCNA has been described in other proliferative cell types, during the M phase of the cell cycle (Iwao et al., 2005). In agreement with these results, hematoxilin-eosin staining shows a dramatic increase in the number of mitotic cells of mesencephalic neuroepithelium (see arrows in Figures 7R,X, and inset in 7X). Furthermore, the apical border of mesencephalic cells is irregular, with the presence of detached cells (Figures 7R,X), and has lost its immunoreactivity for SCOspondin (Figures 7O,U).
In summary, the animals with a SCO-spondin cephalic inhibition have a wider mesencephalon than controls (136 ± 11 μm vs. 75 ± 15μm, Figure 7A ), and also display a smaller area staining positively for βIII tubulin (9.5 ± 7% vs. 25.6 ± 1.7%, Figure 7B ). By contrast, animals with inhibition of SCO-spondin at the level of the caudal region show a mesencephalon similar to control animals concomitantly with a reduced PC area (67.7 ± 9% compared to control animals, Figure 7C ).

EFFECT OF SCO-SPONDIN ON MESENCEPHALIC EXPLANTS
The mesencephalic malformations found in animals in which SCO-spondin was inhibited led us to investigate the long-range function of this protein in vitro, using optic tecta explanted from HH20 chick embryos (Figure 8). On the one hand, we analyzed the effect of SCO-spondin gain of function by comparing DMEM with conditioned DMEM medium that has been in contact with SCO explants that secrete SCOspondin (Figure 2 CM)

DISCUSSION
In this study, we performed, for the first time, an in vivo inhibition of SCO-spondin expression. Furthermore, by targeting the inhibition to different regions of the diencephalic roof plate, we showed that SCO-spondin is a pleiotropic protein, fulfilling different functions according to its secretion mode (Figure 9). When apically secreted, SCO-spondin remains soluble in the eCSF ( Figure 9A) and binds to the apical membrane of neuroepithelial cells, thereby affecting their differentiation and proliferation, while its basal secretion at the level of the PC seems to contribute to the fasciculation and attraction of the PC axons (Figures 9D,E). These results are in agreement with previously reported in vitro experiments in which either SCO-spondin or peptides derived from its sequence promote fasciculation (Stanic et al., 2010), neurite outgrowth (Meiniel et al., 2003;Stanic et al., 2010), and differentiation (Monnerie et al., 1997;El Bitar et al., 2001).

BASALLY SECRETED SCO-SPONDIN REGULATES PC FORMATION
The following previous lines of evidence have led some authors to propose that SCO-spondin contributes to the PC development (Meiniel et al., 2008;Caprile et al., 2009; Hoyo-Becerra  (4) in vitro experiments where the addition of SCO-spondin or peptides derived from its sequence increase neurite length and fasciculation. Here, we provide direct in vivo evidence that SCO-spondin is crucial for PC formation, as its loss of function either causes a marked decrease in the number of axons (animals with total inhibition), a moderate diminution in the number of axons (inhibition at the caudal region), or axonal defasciculation (animals with cephalic inhibition). The different roles observed for SCO-spondin when it is expressed in the cephalic region (fasciculation) and caudal region (incorporation of new axons) could be due to the steep SCO-spondin rostro-caudal expression gradient (Stanic et al., 2010). In this respect it is interesting to note that the presence of integrin β1 (the hypothetical SCO-spondin receptor) in the axonal membrane is negatively correlated to the concentration of its ligand (Condic and Letourneau, 1997). Hence, it is tempting to propose that, in the caudal region, the lower local concentration of SCO-spondin will promote the formation of integrin/SCO-spondin complexes, leading to axonal outgrowth and incorporation of new axons to the PC. According to this model, a higher availability of SCOspondin in the cephalic region will induce the internalization of surface integrins, diminishing the interaction between the axons and their surrounding extracellular matrix, and, in turn, favoring the interaction between neighboring axons (i.e., fasciculation), a process mediated by axonal adhesion molecules, such as NCAM (Van Vactor, 1998).

APICALLY SECRETED SCO-SPONDIN REMAINS SOLUBLE IN THE eCSF AND BINDS NEUROEPITHELIAL CELLS
The apical secretion of SCO-spondin to the CSF and its polymerization to form the RF during late development and adulthood, are widely accepted. However, the presence of a functional and soluble form of SCO-spondin in the eCSF is a matter of recent studies (Hoyo-Becerra et al., 2006;Vio et al., 2008). Our work reveals that from the third day of chick development onward, SCO-spondin is secreted to the eCSF and that it remains soluble at of 175, 140, 65, and 50 kDa; while at later stages additional bands of 350, 300, and 200 kDa appear. The presence of similar molecular weight bands was found in the CSF of 7 days postnatal rats (Vio et al., 2008) using the same antibody (AFRU) as well as the anti-P15 antibody raised against a peptide derived from the bovine SCO-spondin. These observations suggest the existence of several SCO-spondin isoforms generated by alternative splicing and/or by cleavage. This possibility is in agreement with the presence of several transcripts detected by northern-blot using an SCO-spondin-specific probe (Meiniel et al., 2003). A smaller 138 kDa human SCO-spondin isoform has been reported (A2VEC9-2, Uniprot), containing eight LDLR-A, two EGF-like and three TSP domains, but lacking the CTCK domain, responsible for oligomerization. Therefore, it remains possible that the 140 kDa SCO-spondin isoform detected in the eCSF at early developmental stages (Figure 2) correspond to this small isoform, and that the onset of expression of larger isoforms containing the CTCK triggers polymerization and RF formation after the seventh day of development (Schoebitz et al., 1986;Caprile et al., 2009).

REGION SPECIFIC MORPHOGENETIC ROLE OF SCO-SPONDIN
The present work reveals a strong region-specific effect for SCOspondin, as complete or cephalic inhibition severely affects mesencephalic development, while animals with caudal inhibition display an almost normal morphology.
These results suggest that the region of SCO-spondin inhibition is more important than the total area of inhibition, since the presence of few SCO-spondin immunopositive cells in the cephalic region is sufficient to sustain a normal mesencephalic development. While it is possible that the SCO-spondin secreted at the caudal and cephalic region may correspond to distinct isoforms with different roles on PC and mesencephalic development, we favor a second hypothesis according to which the SCO-spondin secretion pathway differs between the caudal and cephalic region. Indeed, we found that animals whose SCOspondin expression is restricted to the cephalic region display an SCO-spondin immunoreactivity in the apical region of mesencephalic cells. In contrast the mesencephalic cells of animals that express SCO-spondin only at the caudal region are devoid of this immunoreactivity.
The secretion of SCO-spondin to the eCSF opens the question about how this protein will spread into the brain cavities The circulation of eCSF at early stages of development is not yet fully understood, since the absence of choroid plexus does not provide the cephalo-caudal directionality of liquid flows observed in the adult. In this respect, recent studies performed in living Xenopus leavis embryos report the existence of a semicircular fluid flow in the telencephalic and mesencephalic cavities, acting the cerebral aqueduct (the region that contacts the SCO and where SCO-spondin is secreted) as a bridge between the eCSF of both cavities (Mogi et al., 2012). The diencephalic roof plate is therefore a favored region whose secretions can efficiently spread into the brain cavities, since they will be carried away both anteriorly (e.g., toward the pineal gland) and posteriorly (e.g., toward the mesencephalic cavity).

SCO-SPONDIN AS A MORPHOGEN CARRIER?
One fundamental issue that still remains to be tackled is the molecular mode of action of SCO-spondin. Our in vitro experiments show that the addition of a SCO-spondin inhibitory antibody diminishes drastically the ability of native eCSF to promote neurodifferentiation (Figure 8). It is known, however, that the eCSF contains a variety of factors involved in brain development such as dystroglycan, retinoic acid, FGF2, or LDL (Gato and Desmond, 2009;Zappaterra and Lehtinen, 2012) suggesting that these factors might influence each other or act redundantly. For instance, more than 60% of the neural differentiation activity exerted by native eCSF requires the presence of LDL (Parada et al., 2008). Interestingly, to fulfill this role, LDL requires the presence of others eCSF components that still remain to be identified (Parada et al., 2008). Considering the presence of several LDLR-A domains in SCO-spondin, it is possible that SCOspondin is involved in the delivery of lipoproteins to neuroepithelial cells. In addition to their function as lipid carriers, LDLR-A domains can also act as carriers for morphogens of the hedgehog (Hh) and Wnt families (Panakova et al., 2005;Willnow et al., 2007). The association between SCO-spondin and lipoproteinsmorphogens could offer an efficient mean to transport them around the whole brain cavities, and to increase the local concentration of such morphogens. Indeed, if this turned out to be the case, each morphogens will be presented as multiple copies on the same lipoprotein particle, generating a multivalent ligand complex able to promote homomeric clustering of their cognate receptors, as well as heterodimeric interaction between different morphogens. Furthermore, the presence of multiple domains in SCO-spondin like TSP, and EFG-like would increase the range of combinatorial interactions between extracellular ligands.
In summary, our work strengthens the idea that SCO-spondin is a multifunctional protein, involved locally in PC development, and also able to exert a long-range function on remotely located regions of the brain. The secretion and diffusion of a soluble form of SCO-spondin into the eCSF allows its binding to the apical surface of the neuroepithelial cells of the diencephalon and mesencephalon, where it triggers signaling events promoting the neuronal differentiation and exit of mitosis. Future challenges will involve deciphering the molecular actors collaborating with SCO-spondin, such as morphogens, receptors, and signaling pathways.

ACKNOWLEDGMENTS
We are grateful to E.M. Rodriguez for kindly providing the rabbit anti-Reissner's fiber glycoproteins antibody (AFRU). This study was supported by a FONDECYT 1110723 grant to T. Caprile.